Intravenous gamma globulin is effective as an urgent treatment in Brucella-induced severe thrombocytopenic purpura

13Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Severe thrombocytopenia is a rare hematologic manifestation of brucellosis, which can occasionally be associated with bleeding into the skin and from mucosal sites. Prompt recognition of this brucellosis complication and aggressive therapy is vital because the mortality rate associated with bleeding into the central nervous system is high. We report a case of a patient infected with Brucella melitensis who was admitted with a severe case of thrombocytopenic purpura. The patient responded well to intravenous gamma globulin (IVIg) treatment with platelet recovery within 2-3 days. For cases of Brucella-induced thrombocytopenic purpura, IVIg may be administered as an urgent therapy until the microbial therapy takes effect. © 2005 Wiley-Liss, Inc.

Cite

CITATION STYLE

APA

Altuntas, F., Yildiz, O., Sari, I., Eser, B., Cetin, M., & Unal, A. (2005). Intravenous gamma globulin is effective as an urgent treatment in Brucella-induced severe thrombocytopenic purpura. American Journal of Hematology, 80(3), 204–206. https://doi.org/10.1002/ajh.20386

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free